{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:00:28Z","timestamp":1774670428457,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00296-020-04587-4","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:03:42Z","timestamp":1587571422000},"page":"1891-1894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adalimumab-induced myasthenia gravis: case-based review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-5722","authenticated-orcid":false,"given":"Eleftherios","family":"Pelechas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-0800","authenticated-orcid":false,"given":"Tereza","family":"Memi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-5428","authenticated-orcid":false,"given":"Theodora E.","family":"Markatseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0326","authenticated-orcid":false,"given":"Alexandros A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"4587_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrrheum.2013","volume":"10","author":"GR Burmester","year":"2014","unstructured":"Burmester GR, Feist E, Dorner T (2014) Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol 10:77\u201388. https:\/\/doi.org\/10.1038\/nrrheum.2013","journal-title":"Nat Rev Rheumatol"},{"key":"4587_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaci.2015.10.023","volume":"137","author":"M Her","year":"2016","unstructured":"Her M, Kavanaugh A (2016) Alterations in immune function with biologic autoimmune disease. J Allergy Clin Immunol 137:19\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2015.10.023","journal-title":"J Allergy Clin Immunol"},{"key":"4587_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00415-015-7963","volume":"263","author":"S Binks","year":"2016","unstructured":"Binks S, Vincent A, Palace J (2016) Myasthenia gravis: a clinical-immunological update. J Neurol 263:826\u2013834. https:\/\/doi.org\/10.1007\/s00415-015-7963","journal-title":"J Neurol"},{"key":"4587_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","volume":"31","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Bernasconi P, Cavalcante P (2018) Myasthenia gravis: from autoantibodies to therapy. Curr Opin Neurol 31:517\u2013525. https:\/\/doi.org\/10.1097\/WCO.0000000000000596","journal-title":"Curr Opin Neurol"},{"key":"4587_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-0035-1558975","volume":"35","author":"KG Gwathmey","year":"2015","unstructured":"Gwathmey KG, Burns TM (2015) Myasthenia Gravis. Semin Neurol 35:327\u2013339. https:\/\/doi.org\/10.1055\/s-0035-1558975","journal-title":"Semin Neurol"},{"key":"4587_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023\u20131036. https:\/\/doi.org\/10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"key":"4587_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960\u2013977. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"key":"4587_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mus.21280","volume":"39","author":"DB Fee","year":"2009","unstructured":"Fee DB, Kasarskis EJ (2009) Myasthenia gravis associated with etanercept therapy. Muscle Nerve 39:866\u2013870. https:\/\/doi.org\/10.1002\/mus.21280","journal-title":"Muscle Nerve"},{"key":"4587_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4587_CR10","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"4587_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cei.12217","volume":"175","author":"JP Sieb","year":"2014","unstructured":"Sieb JP (2014) Myasthenia gravis: an update for the clinician. Clin Exp Immunol 175:408\u2013418. https:\/\/doi.org\/10.1111\/cei.12217","journal-title":"Clin Exp Immunol"},{"key":"4587_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.autrev.2013.09.002","volume":"13","author":"E Kaltsonoudis","year":"2014","unstructured":"Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA (2014) Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 13:54\u201358. https:\/\/doi.org\/10.1016\/j.autrev.2013.09.002","journal-title":"Autoimmun Rev"},{"key":"4587_CR13","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar4582","volume":"16","author":"E Kaltsonoudis","year":"2014","unstructured":"Kaltsonoudis E, Zikou AK, Voulgari PV, Konistsiotis S, Argyropoulou MI, Drosos AA (2014) Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 16:R125. https:\/\/doi.org\/10.1186\/ar4582","journal-title":"Arthritis Res Ther"},{"key":"4587_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1600-0404.2006.00778.x","volume":"115","author":"M Kakoulidou","year":"2007","unstructured":"Kakoulidou M, Bjelak S, Pirskanen-Matell R, Lefvert AK (2007) A clinical and immunological study of a myasthenia gravis patient treated with infliximab. Acta Neurol Scand 115:279\u2013283. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00778.x","journal-title":"Acta Neurol Scand"},{"key":"4587_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","volume":"24","author":"E T\u00fcz\u00fcn","year":"2005","unstructured":"T\u00fcz\u00fcn E, Meriggioli MN, Rowin J, Yang H, Christadoss P (2005) Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. J Autoimmun 24:261\u2013268. https:\/\/doi.org\/10.1016\/j.jaut.2005.01.013","journal-title":"J Autoimmun"},{"key":"4587_CR16","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1212\/01.wnl.0000147242.92691.71","volume":"63","author":"J Rowin","year":"2004","unstructured":"Rowin J, Meriggioli MN, T\u00fcz\u00fcn E, Leurgans S, Christadoss P (2004) Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology 63:2390\u20132392. https:\/\/doi.org\/10.1212\/01.wnl.0000147242.92691.71","journal-title":"Neurology"},{"key":"4587_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1196\/annals.1405.028","volume":"1132","author":"J Rowin","year":"2008","unstructured":"Rowin J (2008) Etanercept treatment in myasthenia gravis. Ann NY Acad Sci 1132:300\u2013304. https:\/\/doi.org\/10.1196\/annals.1405.028","journal-title":"Ann NY Acad Sci"},{"key":"4587_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10072-009-0023-0","volume":"30","author":"JS Lee","year":"2009","unstructured":"Lee JS, Joo IS, Seok JI (2009) Widely varying TNF-alpha levels in patients with myasthenia gravis. Neurol Sci 30:259\u2013262. https:\/\/doi.org\/10.1007\/s10072-009-0023-0","journal-title":"Neurol Sci"},{"key":"4587_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ncl.2018.01.003","volume":"36","author":"M Al-Haidar","year":"2018","unstructured":"Al-Haidar M, Benatar M, Kaminski HJ (2018) Ocular myasthenia. Neurol Clin 36:241\u2013251. https:\/\/doi.org\/10.1016\/j.ncl.2018.01.003","journal-title":"Neurol Clin"},{"key":"4587_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000487132","volume":"79","author":"F Aguirre","year":"2018","unstructured":"Aguirre F, Villa AM (2018) Prognosis of ocular myasthenia gravis in an Argentinian population. Eur Neurol 79:113\u2013117. https:\/\/doi.org\/10.1159\/000487132","journal-title":"Eur Neurol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04587-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:25:42Z","timestamp":1619047542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04587-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4587"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04587-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors (Pelechas, Memi, Markatseli, Voulgari, Drosos) have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This case is complying with the ethical standards of the University Hospital of Ioannina as it has been obtained an informed consent from the presented patient (informed consent has been uploaded as a different file\u2014supplementary material).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}